Introduction Executive Summary Glucosylceramide synthase inhibitors: Overview • Structure • Mechanism of Action Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Glucosylceramide synthase inhibitors– DelveInsight’s Analytical Perspective In-depth Commercial Assessment • Glucosylceramide synthase inhibitors companies’ collaborations, Licensing, Acquisition -Deal Value Trends Glucosylceramide synthase inhibitors Collaboration Deals • Company-Company Collaborations (Licensing / Partnering) Analysis • Company-University Collaborations (Licensing / Partnering) Analysis Late Stage Products (Phase III) • Comparative Analysis Lucerastat: Idorsia Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Mid Stage Products (Phase II) • Comparative Analysis Drug Name: Company Name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Sinbaglustat: Idorsia Pharmaceuticals • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Pre-clinical and Discovery Stage Products • Comparative Analysis Drug Name: Company Name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Glucosylceramide synthase inhibitors Key Companies Glucosylceramide synthase inhibitors Key Products Glucosylceramide synthase inhibitors- Unmet Needs Glucosylceramide synthase inhibitors- Market Drivers and Barriers Glucosylceramide synthase inhibitors- Future Perspectives and Conclusion Glucosylceramide synthase inhibitors Analyst Views Glucosylceramide synthase inhibitors Key Companies Appendix

Table 1 Total Products for Glucosylceramide synthase inhibitors Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Idorsia Pharmaceuticals • Sanofi